BDBM329781 Preparation of (−)-(4R)-6-(4-chlorophenyl)-1-methyl-4-{[5-(pyridin-3-yl)-1,3,4-oxadiazol-2-yl]methyl}-4H-[1,2,4]triazolo[4,3-a][1]benzazepine::US9663523, Example 45

SMILES Cc1nnc2n1-c1ccccc1C(c1ccc(Cl)cc1)=C[C@@H]2Cc1nnc(-c2cccnc2)o1

InChI Key InChIKey=OZUKYYBTCWITSE-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 329781   

TargetBromodomain-containing protein 4(Human)
Bayer Pharma Aktiengesellschaft

US Patent
LigandChemical structure of BindingDB Monomer ID 329781BDBM329781(US9663523, Example 45 | Preparation of (−)-(...)
Affinity DataIC50: 50nMAssay Description:For this purpose, a time-resolved fluorescence resonance energy transfer (TR-FRET) assay was used, which measures the binding between N-terminally Hi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
US Patent